TJS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Lixil Corp

Watchlist Manager

Watchlist

Price: 9.8 EUR -3.92% Market Closed

Market Cap: €2.8B

L	Lixil Corp F:TJS	JP
	Eastern Bankshares Inc F:EB0	US
	Modulight Oyj F:78W	FI
	Latham Group Inc NASDAQ:SWIM	US
T	Takeda Pharmaceutical Co Ltd OTC:TKPHF	JP

Profitability Summary

Lixil Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

34%

Sustainable 3Y Average Gross Margin

33%

Gross Margin is Increasing

31% > 34%

Low Operating Margin

Low 3Y Average Operating Margin

Operating Margin is Increasing

1% > 2%

Low Net Margin

Negative 3Y Average Net Margin

Declining Net Margin

1% > 0%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-3% > 2%

Low ROE

Negative 3Y Average ROE

Declining ROE

2% > 1%

Low ROIC

Negative 3Y Average ROIC

Declining ROIC